A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting & Exhibition, this episode describes the importance of preparation and professionalism throughout the interview process. Listeners can expect to learn tips and tricks for preparing for residency interviews. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join us for a special podcast series spotlighting student member experiences at 2025 Midyear Clinical Meeting & Exhibition in Las Vegas, NV. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be – there is nothing like it!

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

A highlight from Exceptional Sessions at the 2025 Midyear Clinical Meeting & Exhibition, this episode discusses agencies and organizations other than USP that impact how we handle Compounded Sterile Preparations.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, Dr. Anna Dopp and Mr. Tom Kraus discuss the AJHP Editorial "An advocacy roadmap to recognition and payment for pharmacist patient-care services” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Anaphylaxis is an acute, life-threatening allergic reaction with an estimated prevalence of approximately 2% in the United States. Prompt recognition of anaphylaxis is necessary for appropriate treatment. This episode will review pathophysiology, clinical presentation and management of anaphylaxis. CE for this episode expires on December 13, 2027.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join us for a special podcast series spotlighting student member experiences at 2025 Midyear Clinical Meeting & Exhibition in Las Vegas, NV. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be – there is nothing like it!

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join us for a special podcast series spotlighting student member experiences at 2025 Midyear Clinical Meeting & Exhibition in Las Vegas, NV. Hear perspectives from attendees as they seize opportunities to network, learn and attend residency showcase and PPS. Hear firsthand why Midyear is the place to be – there is nothing like it! 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Unhealthy substance use and substance use disorders remain major public health challenges in the United States. As evidence supporting medications for opioid use disorder continues to grow, pharmacists are playing an increasingly important role in managing substance use disorders, particularly by bridging primary care gaps in rural communities and healthcare deserts. This podcast explores how pharmacists are expanding access to care, leveraging telemedicine, collaborating across healthcare teams, and improving public health outcomes.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode discusses the current guidelines for the treatment of adult cardiopulmonary arrest, reviews evidence-based algorithms aimed at improving outcomes of survival and discusses the role of pharmacologic therapies recommended for pulseless rhythms.  CE for this episode expires on November 29, 2027. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join ASHP President, Melanie Dodd, and Vice President of Accreditation Services, Sam Calabrese, as they walk through ASHP’s newly updated strategic plan. Speakers share the story behind the plan’s development, including how member feedback played a pivotal role in shaping its direction to reflect the needs and aspirations of the pharmacy profession. Speakers highlight the five strategic pillars that form the foundation of the plan and discuss how ASHP is already putting these priorities into action.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.